Colistin Resistance: A Simple Test to Combat a Growing Threat
"New phenotypic method offers rapid screening for MCR-1 mediated resistance, crucial for combating antibiotic resistance."
The rise of antibiotic-resistant bacteria poses a significant threat to global health. Polymyxins, including colistin, are often the last line of defense against multidrug-resistant Gram-negative pathogens. However, resistance to these antibiotics is increasing, driven in part by the spread of mobilized colistin resistance (mcr) genes.
A particularly concerning mechanism of resistance is mediated by the mcr-1 gene, which can transfer easily between bacteria, leading to rapid dissemination of colistin resistance. This highlights the urgent need for rapid and accessible screening methods to detect and control the spread of mcr-1-mediated colistin resistance.
Researchers have developed a novel phenotypic method called the Colistin-MAC test, designed for quick and easy screening of MCR-1-mediated colistin resistance. This test leverages the synergy between colistin and dipicolinic acid (DPA) to identify resistant strains, offering a promising tool for combating antibiotic resistance.
How Does the Colistin-MAC Test Work?
The Colistin-MAC test is a broth microdilution method that assesses colistin MIC (minimum inhibitory concentration) in the absence and presence of dipicolinic acid (DPA). DPA is a chelator that can reduce colistin resistance in MCR-1 producing strains.
- A ≥8-fold reduction of colistin MIC in the presence of DPA was observed with 59 mcr-1-positive strains.
- Colistin MICs were unchanged, increased, or at most reduced by two-fold with the 13 mcr-negative colistin-resistant strains.
Why This Test Matters for Combating Antibiotic Resistance
The Colistin-MAC test offers a practical solution for identifying and controlling the spread of MCR-1 mediated colistin resistance. Its simplicity and low cost make it accessible to laboratories with limited resources, enabling widespread surveillance and prompt intervention.
By quickly identifying mcr-1-positive strains, healthcare professionals can implement targeted infection control measures and optimize antibiotic usage, slowing the spread of resistance. This is particularly crucial in low-income settings where advanced molecular diagnostics are not readily available.
While the Colistin-MAC test shows promise, further research is needed to evaluate its performance across a wider range of bacterial species and resistance mechanisms. Continuous refinement and validation will ensure its effectiveness in the ongoing fight against antibiotic resistance, ultimately safeguarding public health.